U.K. Dx zeroes in on bladder cancer biomarkers in urine odor

U.K. researchers say they've come up with a viable bladder cancer test that detects biomarkers for the disease through urine odor. While the test is in its early stages, it worked in preliminary testing on 98 male urine samples--24 from men with bladder cancer--with 96% accuracy. Their diagnostic device relies on the notion that cancer cells emit smelly gases filled with volatile organic compounds unique to the disease. While more testing on larger patient samples is needed, it could someday offer a less-invasive way to test for bladder cancer. More

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.